India to Brazil: Liraglutide Export Trade Route
India has recorded 8 verified shipments of Liraglutide exported to Brazil, representing a combined trade value of $13.1K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $1.6K USD. The leading Indian exporter is ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, which accounts for 39% of total export value with 3 shipments worth $5.2K USD. On the buying side, CIPLA BRASIL IMPORTADORA E DISTRIBU is the largest importer in Brazil with $5.0K USD in purchases. The top 3 suppliers — ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED, INVITRON ADVANCED ANALYTICS PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Liraglutide corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $13.1K USD. The route is dominated by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's liraglutide manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $1.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with liraglutide's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 32.5%, placing it at rank #4 among India's top liraglutide export destinations globally.
On the import side, key buyers of Indian liraglutide in Brazil include CIPLA BRASIL IMPORTADORA E DISTRIBU, CIPLA BRASIL IMPORTADORA E, CIPLA BRASIL IMPORTADORA E DISTRIBULDORA DE MEDICAMENTOS LIMITED. CIPLA BRASIL IMPORTADORA E DISTRIBU is the single largest importer with 2 shipments valued at $5.0K USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ4
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#4
- Annual growth+32.5%
- Demand growth+27.1%
- Regulatory ease72/100
Top 10 Indian Liraglutide Exporters to Brazil
Showing top 10 of 3 Indian suppliers exporting Liraglutide to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI Avg $1.7K per shipment | 3 | $5.2K | 39.5% |
| 2 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED Avg $1.6K per shipment | 3 | $4.8K | 36.5% |
| 3 | INVITRON ADVANCED ANALYTICS PRIVATE LIMITED Avg $1.6K per shipment | 2 | $3.1K | 24.0% |
This table shows the top 10 of 3 Indian companies exporting liraglutide to Brazil, ranked by total trade value. The listed exporters are: ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED, INVITRON ADVANCED ANALYTICS PRIVATE LIMITED. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI is the dominant supplier with 3 shipments worth $5.2K USD, giving it a 39% market share.
Top 10 Liraglutide Importers in Brazil
Showing top 10 of 3 known buyers in Brazil receiving Liraglutide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian liraglutide in Brazil include CIPLA BRASIL IMPORTADORA E DISTRIBU, CIPLA BRASIL IMPORTADORA E, CIPLA BRASIL IMPORTADORA E DISTRIBULDORA DE MEDICAMENTOS LIMITED. The largest importer is CIPLA BRASIL IMPORTADORA E DISTRIBU, accounting for $5.0K USD across 2 shipments — representing 38% of all liraglutide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA BRASIL IMPORTADORA E DISTRIBU | 2 | $5.0K | 38.5% |
| 2 | CIPLA BRASIL IMPORTADORA E | 3 | $4.8K | 36.5% |
| 3 | CIPLA BRASIL IMPORTADORA E DISTRIBULDORA DE MEDICAMENTOS LIMITED | 3 | $3.3K | 25.0% |
Top 10 Liraglutide Formulations Imported by Brazil
Showing top 10 of 8 product formulations shipped on the India to Brazil Liraglutide route, ranked by trade value
Brazil imports a wide range of liraglutide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LIRAGLUTIDE INJECTION 18MG/3ML(6MG/ML), — accounts for $3.8K USD across 1 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LIRAGLUTIDE INJECTION 18MG/3ML(6MG/ML), | 1 | $3.8K | 28.9% |
| 2 | LIRAGLUTIDE INJECTION 6MG/ML | 1 | $3.2K | 24.0% |
| 3 | LIRAGLUTIDE INJECTION18MG/3ML 6MG/ML0.6 MG1.2MG OR 1.8 MG PER DOSE BATCH NO: 306203 | 1 | $1.6K | 12.0% |
| 4 | LIRAGLUTIDE INJECTIONIH18MG/3ML 6MG/ML0.6 MG1.2MG OR 1.8 MG 2.4 MG OR 3.0 MG PER DOSE BATCH NO: 307203 | 1 | $1.6K | 12.0% |
| 5 | PLACEBO FOR LIRAGLUTIDE INJECTION 18MG/3ML(6MG/ML), | 1 | $1.3K | 9.6% |
| 6 | PLACEBO FOR LIRAGLUTIDE INJECTION 6MG /ML | 1 | $904 | 6.9% |
| 7 | (D-ALLO-THR5)-LIRAGLUTIDE (25 MG X 3 VIALS = 75 MG) | 1 | $733 | 5.6% |
| 8 | PLACEBO FOR PHENOL IN LIRAGLUTIDE INJECTION 18MG/3ML 6MG/ML | 1 | $131 | 1.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 5 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's liraglutide exports to Brazil are driven primarily by a handful of large-scale manufacturers. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED, INVITRON ADVANCED ANALYTICS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $1.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as liraglutide injection 6mg/ml and liraglutide injection18mg/3ml 6mg/ml0.6 mg1.2mg or 1.8 mg per dose batch no: 306203, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA BRASIL IMPORTADORA E DISTRIBU is the largest importer with 2 shipments worth $5.0K USD — representing 38% of all liraglutide imports from India on this route.
Route Statistics
- Trade Volume
- $13.1K
- Avg. Shipment
- $1.6K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~28 days
- Annual Growth
- +32.5%
Related Analysis
Reverse Direction
Brazil → India — Liraglutide (Import)Other Liraglutide Routes
Unlock the Full India to Brazil Liraglutide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 8 shipments on this route.
Frequently Asked Questions — India to Brazil Liraglutide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Liraglutide to Brazil?
The leading Indian exporters of Liraglutide to Brazil are ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED, INVITRON ADVANCED ANALYTICS PRIVATE LIMITED. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI holds the largest market share at approximately 39% of total trade value on this route.
Q What is the total value of Liraglutide exports from India to Brazil?
India exports Liraglutide to Brazil worth approximately $13.1K USD across 8 recorded shipments. The average value per shipment is $1.6K USD.
Q Which ports does India use to ship Liraglutide to Brazil?
The most active port of origin is HYDERABAD AIR with 5 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to Brazil for Liraglutide?
The average transit time for Liraglutide shipments from India to Brazil is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Brazil Liraglutide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.5% with demand growth tracking at 27.1%. The route is ranked #4 among India's top Liraglutide export destinations globally.
Q How many suppliers are active on the India to Brazil Liraglutide route?
There are currently 3 active Indian suppliers exporting Liraglutide to Brazil. The market is moderately concentrated with ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI accounting for 39% of total shipment value.
Q Who are the main importers of Liraglutide from India in Brazil?
The leading importers of Indian Liraglutide in Brazil include CIPLA BRASIL IMPORTADORA E DISTRIBU, CIPLA BRASIL IMPORTADORA E, CIPLA BRASIL IMPORTADORA E DISTRIBULDORA DE MEDICAMENTOS LIMITED. CIPLA BRASIL IMPORTADORA E DISTRIBU is the largest buyer with 2 shipments worth $5.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Liraglutide.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 8 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists